Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Condition(s):Nasopharyngeal CarcinomaLast Updated:January 18, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Nasopharyngeal CarcinomaLast Updated:January 18, 2024Active, not recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:March 3, 2014Completed
Condition(s):Oral Squamous Cell CarcinomaLast Updated:November 10, 2022Recruiting
Condition(s):Liver Injury, Drug-InducedLast Updated:March 3, 2017Unknown status
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:December 7, 2009Completed
Condition(s):Head and Neck CancerLast Updated:March 22, 2021Completed
Condition(s):Non-Small-Cell Lung Carcinoma; Carcinoma, BronchogenicLast Updated:April 3, 2009Completed
Condition(s):Neoplasms, MalignantLast Updated:October 16, 2013Completed
Condition(s):Esophageal CancerLast Updated:June 5, 2012Completed
Condition(s):Squamous Cell Carcinoma of Head and NeckLast Updated:October 8, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.